To further investigate whether the upregulation of NF-κB pathway proteins could be considered a “tumor-promoting inflammation” response—a phenomenon commonly observed in human carcinomas—we performed loss-of-function experiments targeting Toll and Imd pathway components. The gene discussed is TLR4; the disease is neoplasm.